We are live on ! Find out more
PCM

Penserra Capital Management Portfolio holdings

AUM $8.52B
1-Year Est. Return 37.76%
This Fund
S&P 500
This Quarter Est. Return
+9.48%
1 Year Est. Return
+37.76%
3 Year Est. Return
+116.32%
5 Year Est. Return
+122.1%
10 Year Est. Return
+1,892.45%
AUM
$5.41B
AUM Growth
+$1.18B
Cap. Flow
+$984M
Cap. Flow %
18.18%
Top 10 Hldgs %
20.49%
Holding
1,162
New
152
Increased
695
Reduced
244
Closed
54

Top Buys

Rank Stock Value
1
BABA icon
Alibaba
BABA
+$64.8M
2
JD icon
JD.com
JD
+$44.9M
3
MELI icon
Mercado Libre
MELI
+$40.5M
4
NTES icon
NetEase
NTES
+$38M
5
BEKE icon
KE Holdings
BEKE
+$21.5M

Top Sells

Rank Stock Value
1
FUTU icon
Futu Holdings
FUTU
+$21.6M
2
TCOM icon
Trip.com Group
TCOM
+$20.5M
3
AOD
abrdn Total Dynamic Dividend Fund
AOD
+$12.1M
4
GDV icon
Gabelli Dividend & Income Trust
GDV
+$12M
5
EFR
Eaton Vance Senior Floating-Rate Fund
EFR
+$11.2M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 33.21%
2 Technology 22.71%
3 Communication Services 13.35%
4 Financials 4.97%
5 Industrials 4.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KZR
1076
DELISTED
Kezar Life Sciences
KZR
$6K ﹤0.01%
106
-7
-6% -$409
NXTC icon
1077
NextCure
NXTC
$26.7M
$6K ﹤0.01%
51
-2
-4% -$290
HTT
1078
High Templar Tech Ltd
HTT
$391M
$6K ﹤0.01%
2,811
+1,874
+200% +$4.47K
RDHL
1079
Redhill Biopharma
RDHL
$3.68M
$6K ﹤0.01%
1
– –
WVE icon
1080
Wave Life Sciences
WVE
$1.2B
$6K ﹤0.01%
1,110
-10
-0.9% -$96
XERS icon
1081
Xeris Biopharma Holdings
XERS
$1.45B
$6K ﹤0.01%
1,355
+200
+17% +$1.08K
EIGR
1082
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$6K ﹤0.01%
25
– –
CNF
1083
CNFinance Holdings
CNF
$37.3M
$5K ﹤0.01%
142
+95
+202% +$3.28K
DNB
1084
DELISTED
Dun & Bradstreet
DNB
$5K ﹤0.01%
210
+140
+200% +$3.36K
HD icon
1085
CALL
Home Depot
HD
$355B
$5K ﹤0.01%
+450
New +$124K
LRMR icon
1086
Larimar Therapeutics
LRMR
$432M
$5K ﹤0.01%
350
-5
-1% -$91
MNOV icon
1087
MediciNova
MNOV
$66M
$5K ﹤0.01%
1,105
+75
+7% +$436
OVID icon
1088
Ovid Therapeutics
OVID
$491M
$5K ﹤0.01%
1,440
-15
-1% -$50
TCDA
1089
DELISTED
Tricida, Inc. Common Stock
TCDA
$5K ﹤0.01%
1,125
-40
-3% -$251
WEI
1090
DELISTED
Weidai Ltd. American depositary shares, each representing five (5) Class A ordinary shares
WEI
$5K ﹤0.01%
751
+501
+200% +$4.11K
AUTL
1091
Autolus Therapeutics
AUTL
$562M
$4K ﹤0.01%
770
-25
-3% -$185
VYGR icon
1092
Voyager Therapeutics
VYGR
$201M
$4K ﹤0.01%
850
-10
-1% -$68
RVLP
1093
DELISTED
RVL Pharmaceuticals plc Ordinary Shares
RVLP
$4K ﹤0.01%
1,420
-55
-4% -$226
CHMA
1094
DELISTED
Chiasma, Inc. Common Stock
CHMA
$4K ﹤0.01%
1,330
-55
-4% -$211
ASMB icon
1095
Assembly Biosciences
ASMB
$529M
$3K ﹤0.01%
71
+8
+13% +$530
OMF icon
1096
OneMain Financial
OMF
$7.47B
$3K ﹤0.01%
66
+44
+200% +$2.27K
JT
1097
DELISTED
Jianpu Technology Inc. American Depositary Shares, each representing twenty Class A Ordinary Shares
JT
$3K ﹤0.01%
1,467
+978
+200% +$2.94K
CNCE
1098
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
$3K ﹤0.01%
730
-10
-1% -$81
CALA
1099
DELISTED
Calithera Biosciences, Inc
CALA
$3K ﹤0.01%
80
-1
-1% -$58
AHG
1100
Akso Health Group
AHG
$1.16B
$2K ﹤0.01%
1,146
+764
+200% +$1.72K
42 43
44
45 46

Similar funds

GRQ
Gardner Russo & Quinn Lancaster, Pennsylvania $8.5B AUM 9.79% 1-Year Est. Return
IC
Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return
NB
Norinchukin Bank Tokyo, Japan $8.57B AUM 20.17% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
ACM
Advisors Capital Management Ridgewood, New Jersey $8.58B AUM 23.43% 1-Year Est. Return
FT
Fiduciary Trust Boston, Massachusetts $8.46B AUM 21.38% 1-Year Est. Return
NW
NewEdge Wealth Pittsburgh, Pennsylvania $8.39B AUM 24.47% 1-Year Est. Return
AAF
Andra AP-fonden Goteborg, Sweden $8.39B AUM 21.19% 1-Year Est. Return

Penserra Capital Management's Q1 2021 Portfolio in Review

As of Q1 2021, Penserra Capital Management held 1,162 positions worth $5.41B, up 28% from $4.23B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Penserra Capital Management deployed $984M of net new capital in Q1 2021, opening 152 new positions and adding to 695 existing holdings. Its largest new stake was BlackRock Resources & Commodities Strategy Trust: 1,847,500 shares worth $16.4M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 33% of assets, down from 35% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was Futu Holdings, an estimated $21.6M trimmed.

  • Penserra Capital Management's largest Q1 2021 buy was BlackRock Resources & Commodities Strategy Trust: 1,847,500 shares worth $16.4M.
  • Penserra Capital Management added most to Alibaba in Q1 2021, an estimated $64.8M increase.
  • Penserra Capital Management's biggest Q1 2021 reduction was Futu Holdings, cutting an estimated $21.6M.
  • Penserra Capital Management fully exited abrdn Total Dynamic Dividend Fund in Q1 2021, selling an estimated $12.1M.
  • Penserra Capital Management's ten largest holdings make up 20% of its $5.41B portfolio in Q1 2021.
  • Penserra Capital Management opened 152 new positions and closed 54 in Q1 2021.
  • Penserra Capital Management's portfolio value rose 28% quarter-over-quarter to $5.41B.

Based on Penserra Capital Management's 13F filing for Q1 2021, filed 13 May 2021.